22. Moyamoya disease
11 clinical trials, 18 drugs (DrugBank: 11 drugs), 28 drug target genes, 43 drug target pathways
Searched query = "Moyamoya disease", "Occlusive disease in circle of Willis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04205578 (ClinicalTrials.gov) | January 2020 | 18/12/2019 | NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events | A Multi-center, Randomized, Single-blind, Placebo-controlled Study of Dl-3-n-butylphthalide in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events After Extracranial-to-intracranial Revascularization Surgery | Moyamoya Disease;Ischemic Cerebral Infarction;Ischemic Stroke;Ischemic Cerebrovascular Accident;Transient Ischemic Attack | Drug: dl-3-n-butylphthalide (NBP);Drug: Normal Saline 0.9% Infusion Solution | yuanli Zhao | Peking University International Hospital | Not yet recruiting | 18 Years | 60 Years | All | 450 | Phase 3 | China |
| 2 | NCT03882060 (ClinicalTrials.gov) | April 8, 2019 | 12/3/2019 | Effect of Recombinant Human EPO on the Postoperative Neurologic Outcome in Pediatric Moyamoya Patients | The Effect of Recombinant Human Erythropoietin on the Postoperative Neurologic Outcome in Pediatric Moyamoya Disease Patients - A Double Blind Randomized Controlled Trial | Moyamoya Disease;Pediatrics;Cerebrovascular Disorders | Drug: erythropoietin;Drug: Normal saline | Seoul National University Hospital | NULL | Recruiting | N/A | 18 Years | All | 82 | N/A | Korea, Republic of |